Invitae launches a genomics-based personalized health management platform
The digital platform aims to enhance patient and provider experiences and further bring genetics to mainstream medicine.
Invitae completes $120M Series F funding
The company will use the proceeds to accelerate the build out of its infrastructure for genetic information business, and expand its global presence.